SHUANGHUA H (01241) announces a net loss of 18.81 million yuan in 2025, an 11.33% increase year-on-year.

23:04 31/03/2026

Shuanghua Holdings (01241) announced its performance for 2025, with revenue of 45,459,000 yuan, a year-on-year decrease of 45.08%; a net loss of 18.81 million yuan, a year-on-year increase of 11.33%; and a loss per share of 2.9 cents.

SHUANGHUA H (01241) announced its performance for 2025, with revenue of 45.459 million RMB, a decrease of 45.08% year-on-year; a net loss of 18.81 million RMB, an increase of 11.33% year-on-year; a loss per share of 2.9 cents.

PHOENITRON HOLD (08066) announces its performance for 2025. The company's net profit attributable to owners is approximately HK$124.82 million, a year-on-year increase of about 26.56 times.

TEDA BIOMEDICAL (08189): Lynn Li appointed as Co-CEO of the company.

TRUE PARTNER (08657) announced its annual performance with a net loss of HK$33.936 million attributable to its shareholders, representing a 30% reduction compared to the previous year.

PHOENITRON HOLD (08066) announces its performance for 2025. The company's net profit attributable to owners is approximately HK$124.82 million, a year-on-year increase of about 26.56 times.

TEDA BIOMEDICAL (08189): Lynn Li appointed as Co-CEO of the company.

TRUE PARTNER (08657) announced its annual performance with a net loss of HK$33.936 million attributable to its shareholders, representing a 30% reduction compared to the previous year.